UBS AM’s Crescent Biopharma CBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding CBIO
OM
UBS AM's CBIO Position: Q3 2026 in Review
UBS AM opened a new position in Crescent Biopharma (CBIO) in Q3 2026: 848 shares worth $12.4K. The stake represents ﹤0.01% of the portfolio and ranks #3754 among its holdings.
105 funds tracked by Wall St. Rank hold CBIO as of Q3 2026.
- UBS AM held 848 shares of Crescent Biopharma worth $12.4K as of Q3 2026.
- Crescent Biopharma was a new UBS AM position in Q3 2026.
- Crescent Biopharma made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #3754 holding.
- 105 funds tracked by Wall St. Rank held Crescent Biopharma as of Q3 2026.
Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.